Hormone replacement therapy for women previously treated for endometrial cancer

  • Protocol
  • Intervention

Authors

  • Xue Peng,

    1. West China Second University Hospital, West China Women's and Children's Hospital, Department of Obstetrics and Gynecology, Chengdu, Sichuan, China
    Search for more papers by this author
  • Jing Fu,

    1. West China Second University Hospital, West China Women's and Children's Hospital, Department of Obstetrics and Gynecology, Chengdu, Sichuan, China
    Search for more papers by this author
  • Hu Lina

    Corresponding author
    1. West China Second University Hospital, West China Women's and Children's Hospital, Department of Obstetrics and Gynecology, Chengdu, Sichuan, China
    • Hu Lina, Department of Obstetrics and Gynecology, West China Second University Hospital, West China Women's and Children's Hospital, No. 17, Section Three, Ren Min Nan Lu Avenue, Chengdu, Sichuan, 610041, China. cqhulina@126.com.

    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effect and safety of HRT for women with endometrial cancer.

To compare the effect and safety of estrogen or estrogen plus progestogens for women with endometrial cancer.